TARO earnings call for the period ending September 30, 2019.
News & Analysis: Taro Pharmaceutical Industries
These three growth stocks are cheap now, but they might not stay cheap for much longer.
Market-trouncing returns could be written in this 4-Star.
Shareholders will no longer have to accept a 24% haircut on their shares.